Mipp is a kelch-related, placental-speci®c gene that is ectopically expressed in many BALB/c mouse mammary carcinomas of various etiologies. The Kelch family encompasses proteins that are emerging as key links between micro®laments and a variety of cellular structures and functions. Mouse mammary tumors express two mipp transcripts (2.2 and 5.6 kb). We cloned the 2.2 kb mipp mRNA and analysed the product of its 1.7 kb ORF. The 584 residue MIPP protein has an N-terminal BTB domain and six C-terminal tandem Kelch repeats. Despite expression of two mipp RNAs, only a single MIPP protein is expressed in mammary tumors. MIPP protein binds to micro®laments in vitro and co-immunoprecipitates with actin. MIPP co-localized with concanavalin A at the endoplasmic reticulum, suggesting that MIPP might mediate interactions between microtubules and actin ®laments. Because MIPP expression is widespread in mouse mammary tumors, it might contribute to tumorigenesis. Although MIPP had little eect on the growth rate of human breast cell lines following transfection, it greatly reduced the formation of duct-like structures on reconstituted basement membrane. Our results suggest that MIPP could contribute to malignant progression in the mouse mammary epithelial cells by perverting their response to cues from the extracellular matrix. Oncogene (2001) 20, 5366 ± 5372.
The mouse model has been crucial in advancing our understanding of the basic cellular mechanisms underlying the development of breast cancer (Gould, 1995; Medina and Daniel, 1996) . In fact, most of what we know about the multi-step process of mammary tumorigenesis stems from rodent models. The identi®-cation of multiple intermediate stages spanning the spectrum from normal to neoplastic mammary epithelium, and the delineation of multiple pathways leading to malignancy have made the mouse model truly indispensable for resolving the events responsible for each step in the evolution of breast cancer (Cardi and Aguilar-Cordova, 1988; Medina, 1988 . The ability to surgically transfer mammary epithelium from one mouse to another, and the availability of mice carrying transgenes, targeted mutations, and conditionally targeted mutations add substantially to the value of the mouse model. The BALB/c mouse is used frequently because it is not infected with exogenous mouse mammary tumor virus (MMTV), making it amenable to studying mammary tumorigenesis arising from spontaneous, hormonal, and chemical etiologies. Despite the analysis of a rapidly expanding list of genes, few, if any known molecular defects are common to the multiple pathways of mammary tumorigenesis resulting from dierent etiologic agents.
We previously found that 2.2 and 5.6 kb mipp mRNA species are expressed in many BALB/c mouse mammary carcinomas regardless of etiology (VanHouten et al., 1996) , suggesting that the mipp gene may contribute to multiple pathways of mammary carcinogenesis. In contrast, mipp expression was not detected in normal mammary gland at any postnatal developmental stage (i.e., virgin, pregnant, lactating) . Moreover, our data showed that the intracisternal A particle (IAP) LTR in the mipp gene does not promote the 2.2, 4.4 and 5.6 kb mipp RNAs, and that all mipp transcripts share a common 3' end (VanHouten et al., 1996) . However, the 5' ends of these mipp mRNAs had not been cloned, and the possible function of mipp in the mammary tumors was unknown.
IAPs are retrotransposons of which 1000 copies are endogenous to the haploid mouse genome (Lueders and Ku, 1977) . A solo long terminal repeat (LTR) from an IAP in the mipp gene of certain mouse strains promotes placenta-speci®c expression of a 1.2 kb message (Chang-Yeh et al., 1991) . All strains of mice express placenta-restricted 2.2 and 4.4 kb mipp-related mRNAs, but only mouse strains with the mippassociated LTR express the 1.2 kb transcript (ChangYeh et al., 1993) . In contrast to the 1.2 kb mipp RNA, the 2.2 and 4.4 kb transcripts have not been cloned, and their promoters have not been identi®ed. The 1.2 kb mipp mRNA contains an open reading frame (ORF) that putatively codes for a 232 amino acid protein with sequence homology to the C-terminal region of Kelch family proteins (Chang-Yeh et al., 1991) . This domain consists of ®ve or six repeating units of 50 amino acids in most Kelch-related proteins, and folds to form a six-bladed b-propeller (also called a superbarrel or b-¯ower) (Bork and Doolittle, 1994; Callebaut and Mornon, 1998) . However, only four repeats are present in the MIPP protein sequence derived from the 1.2 kb RNA. Therefore, this transcript might represent a truncated form of normal mipp RNAs resulting from use of the LTR promoter.
Kelch is a Drosophila protein which cross-links actin ®laments associated with the intercellular bridges (ring canals) connecting the cytoplasm of nurse cells with the oocyte (Robinson and Cooley, 1997; Xue and Cooley, 1993) . In addition to the C-terminal actin-binding repeats, Kelch contains an N-terminal BTB/POZ protein ± protein interaction domain (Albagli et al., 1995) , which mediates homodimerization, thereby cross-linking actin ®laments (Robinson and Cooley, 1997) . The Kelch repeat domains of other proteins (Eichinger et al., 1996; Hernandez et al., 1997; Sanders et al., 1996; Schmid et al., 1994; Soltysik-Espanola et al., 1999 ) also bind to actin ®laments in diverse organisms. Ipp, the human homolog of mipp, has recently been cloned and shown to bind to actin ®laments in vitro via its Kelch repeats . Like other Kelch proteins, IPP contains an Nterminal BTB domain . The cellular location of IPP, however, has not been determined, and in vivo functional studies have not been published. The great similarity between the Kelch repeats of IPP and MIPP suggests that the full-length mipp species (2.2 and 4.4 kb) might also encode a protein(s) with a BTB domain(s).
Herein, we report the cloning and characterization of the full-length 2.2 kb mipp cDNA from mouse mammary tumor RNA. We cloned a 2029 bp fulllength mipp cDNA with a 1.7 kb ORF that is continuous with that of the 1.2 kb mipp cDNA clone (Chang-Yeh et al., 1991) , but without the sequences contributed by the LTR-containing exon. The nucleotide sequence (submitted to GenBank under Accession Number AF285178) of the 2 kb cDNA with translation of the 1.7 kb ORF is shown in Figure 1 . The sequence of the 2 kb mipp cDNA is 83% identical to ipp and 17% identical to kelch at the nucleotide level, and in amino acid sequence MIPP is 87% identical, 91% similar to IPP and 30% identical, 50% similar to Kelch. The mipp sequence was searched against all GenBank sequences, and showed signi®cant similarity to the same sequences reported by Kim et al. (1999) for ipp. The putative product of the 1.7 kb mipp ORF has 584 amino acids, a predicted size of approximately 65.3 kDa, and a predicted pI of 5.35. Several posttranslational modi®cation sites were identi®ed, including one N-glycosylation site, one cAMP/cGMPdependent protein kinase phosphorylation site, nine protein kinase C phosphorylation sites, 11 casein kinase II phosphorylation sites, 17 N-myristoylation sites, and one amidation site. An N-terminal BTB domain (10 ± 134) and six C-terminal tandem Kelch repeats (293 ± 584) were identi®ed by homology searches. MIPP is a cytoplasmic protein by the k nearest neighbors (k-NN) prediction method (Horton and Nakai, 1997) .
Western blots of protein from BALB/c mouse placenta, a D2 mouse mammary tumor, normal lactiferous mammary gland, MOD mouse mammary tumor cells, and EL-12 mouse mammary epithelial cells were immunostained with anti-MIPP and pre-immune serum (Figure 2h ). Tissues and tumors have been described previously (VanHouten et al., 1996) . In placenta, three bands at about 50, 60 and 70 kDa, were detected with anti-MIPP. Although three mipp transcripts are expressed in placenta (1.2, 2.2 and 4.4 kb), the size of the predicted protein from the smallest RNA is 22 kDa (Chang-Yeh et al., 1991) , much less than the smallest protein stained with anti-MIPP (50 kDa). In a D2 tumor and in MOD cells, which express 2.2 and 5.6 kb mipp transcripts, there is a single 70 kDa band, whereas no bands were detected in normal mammary gland or EL-12 cells, which lack mipp RNA (VanHouten et al., 1996) . Pre-immune serum did not stain any of the samples from cells or tissues. Tissue sections from a pregnant mouse's normal mammary gland and from D1 and D2 mammary tumors were also stained with anti-MIPP or pre-immune serum using the indirect immunoperoxidase method. While normal mammary cells and all samples incubated with pre-immune serum did not stain signi®cantly, heavy cytoplasmic staining was observed in the D1 and D2 mammary tumors (not shown).
Because the 70 kDa band was expressed in placenta, D2 tumor, and MOD cells, but not in normal mammary gland or EL-12 cells, the 70 kDa band must be encoded by the 2.2 kb mipp transcript, the only one that placenta and D2 tumors have in common. The dierence between the predicted size of MIPP (65.3 kDa) and the observed size (70 kDa) can be explained by post-translational modi®cation. When D2 tumor RNA was analysed with probes spanning the region between the BTB domain and the Kelch repeats and spanning the entire 1.7 kb ORF, the 2.2 and 5.6 kb bands were both present (not shown). Thus the 3' end of the 5.6 kb transcript probably contains the entire 2.2 kb RNA sequence, while the 5' end is unique. The fact that two mipp mRNAs are expressed in D2 tumors while only one MIPP protein band is expressed strongly suggests that the 5.6 kb transcript has a 5' untranslated region (UTR). Such a long 5' UTR presents intriguing possibilities regarding the regulation of MIPP protein levels.
To determine the subcellular localization of MIPP, MOD cells were stained with anti-MIPP serum using a FITC-conjugated secondary antibody (Figure 2a ± c) . The pattern of anti-MIPP staining was punctate and reticular, extending from the perinuclear area outward, ending before the cortical region of the cell. The lack of staining in EL-12 cells, a negative control for MIPP expression, or of any cells by pre-immune serum, a control for non-speci®c staining, showed that the anti-MIPP staining was speci®c. Since the anti-MIPP staining pattern was reminiscent of endoplasmic reticulum (ER), dual¯uorescence staining was done with tetramethyl-rhodamine-conjugated concanavalin-A (ConA), a commonly used marker for ER (Wood et al., 1981) (Figure 2d ± e). MIPP and rhodamine-ConA exhibited a high degree of coincidence, although there were some non-overlapping areas that stained with one but not the other. Overall, the similarity of the two stains was striking, implying that MIPP may be associated with the ER. Since anti-MIPP localized to some areas where ConA did not, MIPP may also be associated with some non-ER structures.
The Kelch repeats from other proteins, most pertinently IPP , have been shown to bind F-actin, so we tested MIPP for actin-binding activity. The rMKR protein (recombinant MIPP Kelch repeats), which contains MIPP's six C-terminal Kelch repeats with an N-terminal His 6 epitope tag, was assayed for actin-binding activity by co-sedimentation (Figure 3a,b) . After high-speed centrifugation of 1.2 mM rMKR and 12.5 mM actin, approximately 29% of the rMKR and 69% of the actin were found in the pellet. This roughly translates to a molar actin : rMKR binding ratio of 1 : 25. No rMKR sedimented in the absence of actin, nor did His 6 -tagged chloramphenicol acetyltransferase (CAT) co-sediment with F-actin. The physical interaction of MIPP and actin in vivo was analysed using anti-MIPP serum and anti-actin antibodies to immunoprecipitate proteins from lysates of MOD and EL-12 cells (Figure 3c ). When anti-MIPP serum was used for immunoprecipitation, actin (42 kDa) was detected on a Western blot of the precipitated proteins from MOD cells. All samples (MOD and EL-12 cells immunoprecipitated with anti-MIPP or pre-immune serum) had two lower bands on the anti-actin Western blot. The smallest band (22 kDa) corresponds to the immunoglobulin light chain band. The 40 kDa band is non-speci®c, and is frequently seen on Western blots of immunoprecipitates from these cells, regardless of the primary The nested 3' primers were MIPP3B (5'-CGCCGCGGCCGCCATACTCCCAATCCACAGCGGGGG-3') AND MIPP3C (5'-CAUCAUCAUCAUCAGCGGGGGTGATTCATTGAA-3'). The template was 2 ml of oligo-dT-primed cDNA from a D2 tumor prepared as previously described (VanHouten et al., 1996) . The cycling conditions were: denature 25 s at 948C; anneal 1 min at 488C; and extend 2 min at 688C. Next, to clone the remainder of the 5' end of the 2.2 kb mipp transcript, cDNA was synthesized from D2 tumor RNA using the mipp-speci®c primer MIPP3H (5'-ATGGTCAGAACCTACATTTTC-3'). The SMART oligonucleotide (Clontech, Palo Alto, CA, USA) was also added to the RT reaction, and subsequently used as an anchor to perform 5' RACE. Nested PCR reactions were done on 0.5 ml of the cDNA template using MIPP3H and MIPP3B as nested 3' primers. The conditions for the ®rst PCR reaction were: 16 cycles of denaturation at 958C for 15 s, annealing at 568C for 25 s, and extension at 688C for 5 min. The nested reaction used 1 ml of the previous reaction, and consisted of denaturing at 958C for 15 s and annealing/extending at 688C for 5 min for 30 cycles. The full-length cDNA was cloned into the pGEM-T-easy vector (Promega, Madison, WI, USA), and sequenced by RPCI's Biopolymer Core Facility detection antibody or the immunoprecipitating antibody (JN VanHouten, unpublished data). When anti-MIPP or pre-immune serum was used on Western blots of anti-actin immunoprecipitates, the 70 kDa MIPP band was detected in MOD cells. Other bands were detected, including the 22 kDa immunoglobulin light chain band, the 55 kDa heavy chain band, a band at about 80 kDa, and an intense band around 100 kDa. However, these bands are found also in EL-12 cell immunoprecipitates and when pre-immune serum is used to stain the Western blots. Therefore, all bands except the 70 kDa band are non-speci®c. Because anti-MIPP precipitated actin, and anti-actin precipitated MIPP, we concluded that MIPP and actin physically interact in MOD mammary tumor cells.
Integrating the biochemical characterization of MIPP as an actin-binding protein and the localization of MIPP to the ER, we suggest that MIPP might either directly or indirectly mediate an interaction between the ER and the actin cytoskeleton. For instance, the ER vesicles are moved along actin ®laments by myosin V in the giant axon of the squid (Tabb et al., 1998) . In some cell types, ER structure is dependent on the actin cytoskeleton, as the ER undergoes dramatic rearrangement when cells are treated with cytochalasins (Gregory et al., 1999; Ribeiro et al., 1997) . In addition to MIPP, the actin-associated merlin/schwannomin (neuro®bromatosis type 2) protein is located in a perinuclear compartment similar to ER (Schmucker et al., 1997) . The association of microtubules with the ER and vesicle transport is well established, but actin ®laments have also been implicated (reviewed in Terasaki, 1990) . Not only do actin ®laments appear to associate with sub-compartments of the ER distinct from those that associate with microtubules (Gregory et al., 1999; Ribeiro et al., 1997) , but micro®laments and microtubules interact with each other indirectly through linker proteins (Selden and Pollard, 1986; Waterman-Storer and Salmon, 1999) . In yeast, although the structure of the cortical ER does not and the ER marker tetramethylrhodamine-conjugated concanavalin-A (e,g right) had similar staining patterns. Cells were plated on coverslips, grown to near con¯uence, then ®xed and permeabilized with 4% formaldehyde/ 0.1% Triton X-100 in PBS for 15 min at room temperature. The coverslips were rinsed with PBS, and blocking was done for 1 h at room temperature in PBS containing 3% BSA, 10% sheep normal serum, and 0.1% Triton X-100. After rinsing, the coverslips were inverted over 100 ml of anti-MIPP or pre-immune serum at 1 : 500 in PBS, and 1 h later rinsed extensively. The coverslips were next inverted over 100 ml of¯uorescein-conjugated sheep anti-rabbit IgG (Vector, Burlingame, CA, USA) diluted 1 : 400 in PBS, and after 30 min were rinsed as above and mounted on glass slides. For ER localization studies, coverslips were inverted on 100 ml of 50 mg/ml tetramethyl-rhodamine-conjugated concanavalin A (Molecular Probes, Eugene, OR, USA) for 30 min following the secondary antibody step. The cells were photographed at 1006magni®cation. Protein extracts from BALB/c mouse placenta, D2 mammary tumor, normal lactiferous mammary gland, MOD cells, and EL12 cells were analysed for MIPP protein expression by Western blotting with serum raised against a His 6 -tagged recombinant MIPP protein produced in E. coli from the 1.7 kb ORF (h). Sodium dodecyl sulfate-containing polyacrylamide gel electrophoresis (SDS ± PAGE) was done using standard methods (Laemmli, 1970) . Anti-MIPP serum or preimmune serum was diluted 1 : 1000 in the blocking solution (5% non-fat dry milk in PBS with 10% goat serum). Peroxidaseconjugated secondary antibodies with a chemiluminescent detection system were used. To produce the antiserum, the mipp cDNA was cloned into pProEX-HTc (Life Technologies, Grand Island, NY, USA). The recombinant MIPP (rMIPP) was puri®ed by immobilized metal anity chromatography (IMAC) on nickel nitrilo-tri-acetic acid resin (Life Technologies, Grand Island, NY, USA). To prepare the immunogen, rMIPP was separated by SDS ± PAGE and transferred to PVDF. A thin strip was cut from the blot and immunostained with an anti-His 6 monoclonal antibody (Roche, Indianapolis, IN, USA). The anti-His 6 positive bands were homogenized in 10 ml DMSO. The DMSO was evaporated, and the dry blot pulp was dissolved in 1 ml of PBS with 0.1% Tween-20. Two female Elite New Zealand White rabbits (Covance, Princeton, NJ) were pre-bled 2 weeks prior to immunization with rMIPP. For the ®rst injection, 1 ml/rabbit was given of an emulsion made from 0.5 ml of Freund's complete adjuvant and 0.5 ml of the rMIPP immunogen. For subsequent injections, Freund's incomplete adjuvant was used. Anti-MIPP serum was found to be highly speci®c by ELISA (not shown) Figure 3 To determine whether the Kelch repeat domain of MIPP can bind actin ®laments in vitro, this domain was produced in E. coli and subjected to an actin co-sedimentation assay essentially as in (Carraway and Carraway, 1992) . First, high ®delity PCR was used to amplify the cDNA encoding the MIPP Kelch repeats (MKRs). The primers were KELREP5 (5'-GCGGATCCGAGTACTGTGAGGTCTGCAA-3') and KEL-REP3
(5'-GCGAATTCCTCTGTCACAGTACAGCAAC-3'). The PCR product was cloned into pProEx-HTb and the recombinant protein rMKR was produced in and puri®ed from E. coli by IMAC. The rMKR protein and His 6 -tagged CAT as a negative control were dialyzed twice against 2 l of actin binding buer (ABB: 10 mM TrisHCl, 100 mM KCl, 2 mM MgCl 2 , 1 mM CaCl 2 , 0.5 mM adenosine triphosphate (ATP), 0.5 mM dithiothreitol) at 48C for 12 h (MW cut-o 10,000). The proteins were concentrated with C-10 Centricon spin-®lters (Millipore, Bedford, MA). Rabbit skeletal muscle actin (Cytoskeleton Inc., Denver, CO, USA) was resuspended at 25 mM in ABB, and polymerized at room temperature for 1 h 1.2 mM of either rMKR or CAT was incubated with 12.5 mM actin for 1 h at room temperature in a volume of 25 ml. Two additional controls were done: 1.2 mM rMKR alone, to rule out autonomous sedimentation, and 12.5 mM actin alone to ensure the actin had polymerized. The actin ®laments and bound proteins, were pelleted in a Beckman Airfuge (Fullerton, CA, USA) at maximum speed for 1 h using an A100/ 18 rotor. The supernatant (S) and pellet (P) fractions were analysed by Western blotting after the pellets were washed twice. The immunoblots (a) were done with anti-His6 (top panels), and anti-actin (lower panels) monoclonal antibodies. The Un-Scan-It densitometry program was used to determine the relative intensities of the bands for determination of the molar binding ratio of rMKR to actin (b). To determine whether MIPP binds actin in vivo, anti-MIPP serum was used to co-immunoprecipitate actin from lysates of MOD cells (c). Reciprocally, MIPP protein was immunoprecipitated with an anti-actin monoclonal antibody. Negative controls included pre-immune serum for immunoprecipitation and Western blotting with anti-MIPP, and EL-12 cells, which do not express MIPP. In the left panel, immunoprecipitation was done with anti-actin and then Western blotted with anti-MIPP or pre-immune serum (PI). In the right panel, immunoprecipitation was done with anti-MIPP or pre-immune serum followed by Western blotting with anti-actin. The molecular weight (kDa) of co-immunoprecipitated proteins is shown to the left of each panel ) and grown overnight. Linearized pGL3.M4 (2 mg) was mixed with 75 ml DMEM and 400 ng pcDNA3.1(+) (Stratagene, La Jolla, CA). As a control for transfection, 2 mg pcDNA3.1 was used. Transfections were done with lipofectamine (Life Technologies). 48 h after transfection, cells were selected and maintained in the presence of 500 mg/ml geneticin (G418; Life Technologies). Pools of stable transfectants were analysed after 1 month of selection, and RNA was analysed for expression of mipp (full-length cDNA probe) or neo (probed with the 735 bp NcoI fragment of pcDNA3.1) by Northern blotting as previously described (VanHouten et al., 1996) . Protein from these stable transfectants was Western blotted using anti-MIPP or pre-immune serum. Dual immuno¯uorescence staining of HBL-100 cells transfected with MIPP or pcDNA3.1 using tetramethyl rhodamine-ConA and anti-MIPP or pre-immune serum (PI) with a¯uorescein-conjugated secondary antibody was done (c). The cells were photographed at 506magni®cation. Some areas where MIPP and ConA co-localize are indicated with arrowheads. To determine if there was a dierence in the type of multicellular structures formed by HBL-100 (d,e) and MCF-7 (f,g) cells which express MIPP (d,f) and those which do not (e,g) transfected cells were cultured on a reconstituted basement membrane from Engelbreth-Holm-Swarm tumor (EHS; provided by Dr L Varela). A base coat was made by adding 300 ml of diluted EHS (4 ml EHS per 1 ml DMEM) to each well of a 24-well plate. After setting for 2.5 h at 378C, 10 5 cells in 1 ml of DMEM+FBS pre-warmed to 378C were layered over the EHS base coat. The cells were grown on EHS at 378C for 48 h, ®xed in buered formalin, and photographed at 406. The photographs were scanned and enhanced using Paint Shop Pro software's`glowing edges' and`inverse' ®lters depend on micro®laments, the actin cytoskeleton does play a role in ER dynamics (Prinz et al., 2000) . Of note, Goode et al. (2000) have suggested that the Kelch-related protein Tea1p (Mata and Nurse, 1997) functions in polarized cell growth in S. pombe by coupling microtubules to assembly of actin structures at the cell poles. However, Tea1p has not yet been shown to bind actin ®laments. Although direct evidence for interaction with both microtubules and micro®laments is lacking, a picture is emerging in which some Kelch family proteins, including MIPP, might be spatially regulated by microtubules to cause local alterations in actin-based structure formation.
The high frequency of ectopic mipp expression in both mouse mammary preneoplasias and tumors (VanHouten et al., 1996) raised the possibility that MIPP might contribute to at least some pathways of neoplastic progression in the mammary gland. To test this hypothesis, we analysed the eect of MIPP expression on two human breast cell lines. In the HBL-100 and MCF-7 cell lines, MIPP and ConA retained their pattern of co-localization (Figure 4c ). MIPP expression had little eect on the growth rate of either HBL-100 or MCF-7 cells (not shown). However, MIPP expression markedly inhibited mammary ductal morphogenesis on EHS matrix in both cell types (Figure 4d ± g ). Since the primary functions of the actin ®lament network include mediating and maintaining cell shape, and participating in cell ± cell and cell ± extracellular matrix contact and communication, MIPP expression could alter the actin cytoskeleton, and therefore the way cells arrange themselves on a given extracellular matrix. MIPP-expressing cells looked less organized and less dierentiated than control cells. This eect could be related to the potential of MIPP to in¯uence malignant progression. Future experiments should determine the tumorigenicity and metastatic potential of these MIPP-transfected cells in an animal model.
Most mouse mammary tumors contain speci®c genetic abnormalities that depend on the particular etiology of the tumor. For example, speci®c ras mutations are associated with DMBA-and NMUinduced tumors, whereas wnt and int activation are associated with MMTV-induced tumors. Mipp expression is one of the few known aberrations identi®ed in a high percentage of mouse mammary carcinomas independent of the inducing agent. In the present study, we established several important points about the mipp transcripts and protein that are expressed ectopically in mouse mammary carcinomas.
Although activation of mipp is a frequent event in BALB/c mouse mammary tumorigenesis (VanHouten et al., 1996) , mipp does not appear to be expressed in benign or malignant human breast cell lines by RT ± PCR (not shown). Therefore it may not be involved in human breast cancer. However, another protein(s) may provide a similar function in the human disease. The study of mipp may provide insights into the human disease by helping to elucidate the basic mechanisms of tumorigenesis. Since MIPP inhibits mammary morphogenesis in vitro, but does not increase cellular growth rate, it may, for instance, facilitate the disruption of the normal spatial growth constraints on the mouse mammary epithelium during tumorigenesis.
